Company Information
CIN
Status
Date of Incorporation
22 December 2015
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2023
Last Annual Meeting
27 September 2023
Paid Up Capital
4,000,000
Authorised Capital
4,000,000
Directors
Reena Srivastava
Director/Designated Partner
over 2 years ago
over 2 years ago
Seema Kaul
Director/Designated Partner
over 2 years ago
over 2 years ago
Prashant Pareek
Director/Designated Partner
over 2 years ago
over 2 years ago
Past Directors
Nitish Dhingra
Additional Director
almost 9 years ago
almost 9 years ago
Palak Kalia
Additional Director
almost 9 years ago
almost 9 years ago
Rishi Mohan Srivastava
Additional Director
over 9 years ago
over 9 years ago
Shuchi Pareek
Director
almost 10 years ago
almost 10 years ago
Registered Trademarks
[Class : 5] Tablet Consist Of Molecule Dapagliflozin Indicated For Treatment Of Diabetic Kidney Disease And Chronic Kidney Disease.
[Class : 5] Medicine In The Form Of
Tablet Used To Treat Vitamin Deficiency
Arising Out Of Chronic Kidney Disease.
[Class : 5] Pharmaceutical And Medicinal Preparations; Dietetic Food And Substances Adapted For Medical Use; Dietary Supplements For Humans.
Renewal of trademark is due. Renewal request in prescribed form is to be filed by the applicant.
View +13 more Brands for Akognos Life Sciences Private Limited.
Charges
01 December 2017
Allahabad Bank
97 Lak
26 May 2017
Lord Krishna Financial Services Limited
14 Lak
01 December 2017
Indian Bank
0
26 May 2017
Others
0
01 December 2017
Indian Bank
0
26 May 2017
Others
0
